https://www.idival.org/wp-content/uploads/2022/05/cab-presentacion.jpg

Fourth Edition of the MINDS Master’s Program: A Consolidated Community of Leaders in Healthcare Innovation

11 de August de 2025

Since its launch in 2021, the Master’s in Health Innovation Management and Leadership (MINDS) has achieved much more than training professionals: it has built a vibrant and transformative community around healthcare innovation. Backed by IDIVAL and driven by an interdisciplinary team of experts in management, healthcare, research, and entrepreneurship, the program now enters its fourth […]

Read more →

Fourth Edition of the MINDS Master’s Program: A Consolidated Community of Leaders in Healthcare Innovation

8 de August de 2025

Since its launch in 2021, the Master’s in Management and Leadership of Healthcare Innovation (MINDS) has achieved far more than training professionals: it has built a vibrant, transformative community around healthcare innovation. Backed by IDIVAL and driven by an interdisciplinary team of experts in management, healthcare, research, and entrepreneurship, the program now enters its fourth […]

Read more →

New Insights into the Side Effects of a Recent Rheumatoid Arthritis Treatment

4 de August de 2025

A study led from Cantabria analyzes how JAK-STAT pathway inhibitors affect the immune system The Immunopathology Research Group at the Marqués de Valdecilla Research Institute (IDIVAL), which includes professionals from the Marqués de Valdecilla, Laredo, and Sierrallana hospitals, has published a study that sheds new light on how a recently introduced treatment for rheumatoid arthritis […]

Read more →

New Test Detects Carriers of a Rare Mutation Without the Need for Genetic Analysis

21 de July de 2025

Researchers in Cantabria develop a simple, cost-effective test to help diagnose patients with low alkaline phosphatase levels Researchers from the Marqués de Valdecilla Research Institute (IDIVAL) and the Rare Diseases Unit at the Marqués de Valdecilla University Hospital (HUMV) have developed a new diagnostic method capable of identifying carriers of mutations in the ALPL gene, […]

Read more →

Update of the HRS4R Action Plan: IDIVAL moves towards more ethical, open, and professional research

16 de July de 2025

The Marqués de Valdecilla Health Research Institute Foundation (IDIVAL) joined the European Human Resources Strategy for Researchers (HRS4R) in 2016 and obtained the “HR Excellence in Research” award in October 2018. This quality recognition is a key criterion for the renewal of accreditation as a Health Research Institute by the Carlos III Health Institute (ISCIII), […]

Read more →

A Device That Improves the Experience of Patients With Multiple Myeloma, Assessed in a Study With Participation From IDIVAL

14 de July de 2025

Nurses Nuria Sánchez and Paula Calvo, from the Clinical Trials Unit of the Marqués de Valdecilla University Hospital (HUMV/IDIVAL), have participated in an international study conducted within the framework of a clinical trial led by the Hematology Department. The results have just been published, providing the nursing staff’s perspective on a new drug delivery device […]

Read more →

The ‘Luchamos por la Vida’ Association donates €20,000 to IDIVAL for aggressive breast cancer research

8 de July de 2025

The donation is the result of the 15th edition of their solidarity event held in Los Corrales de Buelna, which brought together thousands of people in support of biomedical research in Cantabria. The Marqués de Valdecilla Research Institute (IDIVAL) received a €20,000 donation from the ‘Luchamos por la Vida’ Association, aimed at supporting a research […]

Read more →

IDIVAL’s Board of Trustees Approves Annual Accounts and Consolidates Its Growth as a Benchmark in Biomedical Research

7 de July de 2025

The Board of Trustees of the Marqués de Valdecilla Research Institute Foundation (IDIVAL) has approved its annual accounts for the 2024 financial year, confirming the institution’s financial stability and soundness. The meeting, held at the Government Pavilion of the University of Cantabria, also provided an opportunity to review a year marked by continuous growth in […]

Read more →

IDIVAL allocates over €460,000 to its research groups to boost scientific output in Cantabria

4 de July de 2025

The Marqués de Valdecilla Research Institute (IDIVAL) has allocated €465,000 this year to support the activity of the 30 research groups that make up the institute. This amount represents a significant increase compared to previous calls and is part of the Support program, which provides backing for the development of activities by IDIVAL’s research groups. […]

Read more →

IDIVAL researchers identify the key role of a neuropeptide in the gut-brain connection

3 de July de 2025

The Clinical and Translational Research Group in Digestive Diseases at the Marqués de Valdecilla Research Institute (IDIVAL) has just published an article in the Revista Española de Enfermedades Digestivas, reviewing and updating current knowledge on the calcitonin gene-related peptide (CGRP) and its role in the bidirectional communication between the central nervous system and the gastrointestinal […]

Read more →